Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study

被引：38
|
作者：
Durand, Christine M. [1 ]
Barnaba, Brittany [1 ]
Yu, Sile [1 ]
Brown, Diane M. [1 ]
Chattergoon, Michael A. [1 ]
Bair, Nichole [1 ]
Naqvi, Fizza F. [1 ]
Sulkowski, Mark [1 ]
Segev, Dorry L. [1 ]
Desai, Niraj M. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
ANNALS OF INTERNAL MEDICINE | 2021年 / 174卷 / 01期
关键词：
D O I：
10.7326/M20-1468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：137 / 138
页数：2
相关论文
共 50 条
  • [41] Twelve Month Outcomes of Kidney Transplantation from Hepatitis C Viremic Deceased Donors to Aviremic Recipients.
    Binari, L. A.
    Forbes, R. C.
    Rega, S.
    Feurer, I. D.
    Dreher, A.
    Shawar, S.
    Schaefer, H.
    Shaffer, D.
    Concepcion, B. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1067 - 1068
  • [42] Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation From Hepatitis C Virus Positive Donors
    Smith, Deane E.
    Chen, Stacey
    Fargnoli, Anthony
    Lewis, Tyler
    Galloway, Aubrey C.
    Kon, Zachary N.
    Moazami, Nader
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (02) : 407 - 415
  • [43] Expanded Experience with Ultra-Short Duration Pangenotypic Direct Acting Anti-Viral (DAA) Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic (HCV) Donors to Hepatitis C Negative Kidney Transplant Recipients (KT).
    Yakubu, I.
    Kumar, D.
    Sharma, A.
    Levy, M.
    Kamal, L.
    Gupta, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 573 - 573
  • [44] Efficacy and Safety of Direct-Acting Antivirals in Kidney Transplantation From HCV-Viremic Donors to Negative Recipients: A Meta-Analysis
    Feng, Zepei
    Zhang, Jinwei
    Tan, Weilong
    Wang, Chunhui
    Chen, Qiong
    Shen, Chao
    Fan, Haozhi
    Zhang, Yun
    Huang, Peng
    Yue, Ming
    FRONTIERS IN MEDICINE, 2022, 9
  • [45] REHANNA: Renal Transplants in Hepatitis C Negative Recipients with Nucleic Acid Positive Donors with Short Course Direct Acting Antiviral Prophylaxis.
    Durand, C.
    Barnaba, B.
    Brown, D.
    Bair, N.
    Naqvi, F.
    Bowring, M.
    Segev, D.
    Sulkowski, M.
    Desai, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1121 - 1121
  • [46] Liver transplantation for Hepatitis C patients in the era of direct-acting antiviral treatment: An evolving revolution - An invited commentary on "Liver transplantation for Hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study" Comment
    Purcell, Laura N.
    Charles, Anthony
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 76 : 48 - 48
  • [47] Use of Hepatitis-C Treatments after Kidney Transplantation: Impact of the Direct-Acting Antiviral Era.
    Lentine, K.
    Axelrod, D.
    Bloom, R.
    Xiao, H.
    Segev, D.
    Alhamad, T.
    Randall, H.
    Ouseph, R.
    Dharnidharka, V.
    Brennan, D.
    Lam, N.
    Naik, A.
    Hess, G.
    Kaiske, B.
    Schnitzler, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 261 - 262
  • [48] Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study
    Khan, Adeel S.
    Adams, Nathaniel
    Vachharajani, Neeta
    Dageforde, LeighAnne
    Wellen, Jason
    Shenoy, Surendra
    Crippin, Jeffrey S.
    Doyle, Majella B.
    Chapman, William C.
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 75 : 84 - 90
  • [49] Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients
    Binari, Laura A.
    Thorne, Peter
    Rega, Scott A.
    Feurer, Irene D.
    Shawar, Saed
    Naik, Ruchi
    Birdwell, Kelly A.
    Helderman, J. Harold
    Langone, Anthony
    Sarrell, Bonnie Ann
    Schaefer, Heidi
    DuBray, Bernard John
    Eid, Kareem
    Hickman, Laura
    Shaffer, David
    Concepcion, Beatrice P.
    Forbes, Rachel C.
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (01)
  • [50] Direct-acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver-kidney transplant recipients
    Nookala, Anupama U.
    Crismale, James
    Schiano, Thomas
    Te, Helen
    Ahn, Joseph
    Robertazzi, Suzanne
    Rodigas, Colleen
    Satoskar, Rohit
    Mandip, K. C.
    Hassan, Mohamed
    Smith, Coleman
    CLINICAL TRANSPLANTATION, 2018, 32 (03)
12345